Stephens Inc Novartis Ag Transaction History

Stephens Inc

$6.84 Billion
Q4 2024

A detailed history of Stephens Inc transactions in Novartis Ag stock. As of the latest transaction made, Stephens Inc holds 6,484 shares of NVS stock, worth $693,204. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,484

Previous 6,415 1.08%

Holding current value

$693,204

Previous $737,000 14.52%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$96.78 - $117.18 $6,677 - $8,085	69 Added 1.08%	6,484 $630,000
Q3 2024 Oct 28, 2024	SELL	$106.13 - $120.89 $68,135 - $77,611	-642 Reduced 9.1%	6,415 $737,000
Q2 2024 Aug 06, 2024	BUY	$92.57 - $107.37 $9,349 - $10,844	101 Added 1.45%	7,057 $751,000
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $7,716 - $8,786	81 Added 1.18%	6,956 $672,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $3,044 - $3,350	-33 Reduced 0.48%	6,875 $694,000
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $37,228 - $41,316	-393 Reduced 5.38%	6,908 $703,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $4,348 - $4,930	-47 Reduced 0.64%	7,301 $736,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $52,659 - $61,068	658 Added 9.84%	7,348 $676,000
Q4 2022 Jan 25, 2023	SELL	$75.55 - $92.52 $110,982 - $135,911	-1,469 Reduced 18.0%	6,690 $607,000
Q3 2022 Nov 02, 2022	SELL	$74.61 - $87.26 $57,151 - $66,841	-766 Reduced 8.58%	8,159 $620,000
Q2 2022 Aug 03, 2022	SELL	$80.52 - $93.75 $50,325 - $58,593	-625 Reduced 6.54%	8,925 $754,000
Q1 2022 May 04, 2022	SELL	$80.11 - $90.62 $214,855 - $243,042	-2,682 Reduced 21.93%	9,550 $838,000
Q4 2021 Mar 07, 2022	SELL	$79.7 - $88.13 $1.31 Million - $1.45 Million	-16,443 Reduced 57.34%	12,232 $1.07 Million
Q3 2021 Oct 27, 2021	BUY	$81.78 - $95.14 $368,827 - $429,081	4,510 Added 18.66%	28,675 $2.35 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $83,023 - $91,702	974 Added 4.2%	24,165 $2.21 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $439,043 - $517,755	-5,258 Reduced 18.48%	23,191 $1.98 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $13,428 - $16,241	172 Added 0.61%	28,449 $2.69 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $240,341 - $266,266	-2,926 Reduced 9.38%	28,277 $2.46 Million
Q2 2020 Aug 24, 2020	BUY	$80.93 - $91.1 $123,337 - $138,836	1,524 Added 5.13%	31,203 $2.73 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $325,364 - $455,842	4,604 Added 18.36%	29,679 $2.45 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $28,257 - $31,948	-335 Reduced 1.32%	25,075 $2.37 Million
Q3 2019 Oct 18, 2019	SELL	$85.54 - $94.26 $29,425 - $32,425	-344 Reduced 1.34%	25,410 $2.21 Million
Q2 2019 Aug 01, 2019	BUY	$75.4 - $92.8 $98,698 - $121,475	1,309 Added 5.35%	25,754 $2.35 Million
Q1 2019 May 03, 2019	BUY	$75.32 - $86.15 $134,747 - $154,122	1,789 Added 7.9%	24,445 $2.35 Million
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $10,386 - $11,564	141 Added 0.63%	22,656 $1.94 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $176,922 - $204,647	2,643 Added 13.3%	22,515 $1.94 Million
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $1.29 Million - $1.46 Million	19,872 New	19,872 $1.5 Million

Others Institutions Holding NVS

# of Institutions

1,472

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account